Key takeawaysUCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

Discover groundbreaking research on pulmonary fibrosis and a potential new treatment target that could revolutionize lung ...

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies are attracting ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...